Ken Griffin acquired 4.27 Million Ventyx Biosciences shares worth $18.6 Million. That's 0.02% of their equity portfolio (831st largest holding). The investor owns 5.89% of the outstanding Ventyx Biosciences stock. The first Ventyx Biosciences trade was made in Q4 2021. Since then Ken Griffin bought shares four more times and sold shares on four occasions. The investor's estimated purchase price is $75.5 Million, resulting in a loss of 75%.